Stress urinary incontinence after radical prostatectomy
Conditions
Interventions
treatment group (received a single injection into the urethral rhabdosphincter 10ml of ADSC solution)
placebo group (single injection into the urethral rhabdosphincter of 10ml of normal saline).
Sponsors
Al Zahraa Hospital, Beirut, Lebanon
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: patients with an stress urinary incontinence for > 18 months after surgery, localized low to intermediate-risk prostate cancer before surgery, have no biochemical recurrence at study enrollment, the patient had no adjuvant chemotherapy or radiotherapy, all patients had pelvic floor training for > 6 months. All patients had office cystoscopy before entering the study to exclude bladder neck contracture or urethral stenosis
Exclusion criteria
Exclusion criteria: patients taking anticholinergic medications for overactive bladder symptoms or taking a diuretic for heart failure, patients with urinary tract infection, patients with any neurologic disease that may affect bladder function
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes of our study were the change from baseline in the mean of the 24-h pad weight test. | — |
Countries
Asia(except Japan)
Contacts
Public ContactMohamad Moussa
Lebanese Univeristy Stem Cell Center
Outcome results
None listed